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Objectives: The off-pump trans left ventricular
approach provides an alternative option for inser-
tion of stented aortic valves of any size for endovas-
cular replacement. One of the key steps in this pro-
cedure is the repair of the ventricle after catheter
withdrawal. This study evaluates the reliability of
a new device for sutureless and quick repair of the
left ventricle access. 
Methods: The Amplatz-nitinol occluder con-
sists of two square heads that squeeze the ventricle
wall between them thus sealing the ventricular
defect. In four adult pigs weighing 55 kg, left tho-
racoscopy was performed to open the pericardium
and visualise the cardiac apex. Following a heparin
injection (100 U/kg) under ICUS and fluoroscopic
control, we inserted a 30 F sheath into the epigas-
tric area through the cardiac apex up into the left
ventricle thus simulating the approach for an off-
pump aortic valve replacement. The sheath was
then removed and the ventricle closed with the oc-
cluder. Animals were followed-up for three hours;
the haemodynamics and pericardial bleeding were
recorded. The animals were then sacrificed and the
gross anatomy of the heart was examined.
Results: The device was successfully deployed
in four animals in less than one minute. ACT was
above 200 seconds in all cases. All animals sur-
vived the procedure with a mean arterial pressure
of 50±15 mm Hg. Bleeding during deployment was
80±20 ml and over a 3 hour period was 800±20 ml.
Examination of the gross anatomy examination
demonstrated the correct positioning of the device.
Conclusions: The occluder is easy to use and the
procedure is feasible and reproducible. However,
the occluder design requires technical improve-
ments in order to reduce bleeding before it can be
used clinically.
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Off pump aortic valve replacement cannot be
considered a new approach since Davies deployed
a catheter-mounted unicuspid valve above the aor-
tic valve for the temporary relief of aortic insuffi-
ciency in 1965 [1]. Many other authors have mod-
ified and improved the endovascular approach for
aortic valve replacement using stented valves [2–4].
However, the endovascular approach still has sev-
eral limitations: the size of the valve is limited by
the delivery sheath diameter therefore only small
stented valves can be implanted; the precise posi-
tioning of the stented valve onto the aortic annu-
lus or supra-annular position is cumbersome be-
cause it is very difficult to properly drive long and
stiff catheters into the arterial tree. The off pump
trans-left ventricle approach overcomes all these
limitations. It allows more precise deployment of
stented aortic valves of any size with respect to the
endovascular replacement as has been demon-
strated in our previous studies [5, 6]. One of the
key steps in this procedure is the ventricle repair
after catheter withdrawing. The closure of the left
ventricle access is a challenging procedure even
when the open chest approach supported with ex-
tracorporeal circulation is used. Moreover, there is
a consistent risk of air embolism. 
Recent developments in sutureless devices for
septal defect repairs appear to provide a tool allow-
ing easy and safe closure of the ventricle access.
However, these devices have been designed to deal
with low-pressure systems and it would be helpful
to assess if current design shape, number of wires,
dimensions, etc provide a sealing effect compa-
rable to the open surgical technique when applied
to high-pressure systems.
We designed an animal study to assess the re-
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liability of a new device for sutureless and quick
repair of the left ventricle access. The endpoint of
the study is to assess the feasibility of the deploy-
ment procedure and to its effect on haemodynamic
stability.
Materials and methods
The occluder
The occluder 12 mm Amplatz (AGA, Golden Valley,
MN) is made of a nickel – titanium alloy with a pre-deter-
mined thermal memory shape. It consists of two square
heads that squeeze the ventricle wall between them seal-
ing the ventricular defect (figure 1). A third element, a
semi rigid guide wire, is secured to the device to aid inser-
tion. This element is unscrewed once insertion is com-
pleted. The device is mounted in a 30 F sheath to simu-
late the use of a 25 mm stented valve. The insertion be-
gins in the left ventricle with release of the endocardial
square head. The guide wire is gently pulled back until the
square head is in contact with the ventricle wall. The
second head is then released pulling back the sheath and
the guide wire is unscrewed. 
Study design
An acute in vivo evaluation was performed in four
adult pigs, weighing 55± 4.3 kg (range 43–56 kg), equipped
with an arterial pressure line in the right carotid artery and
ECG. Under general anaesthesia, left thoracoscopy was
used to open the pericardium. One 12 mm port was in-
serted into the 7th intercostal space for the camera and two
5 mm ports were inserted into the 11th and 5th spaces re-
spectively. A pericardial window 4  3 cm was then cre-
ated in order to visualise the cardiac apex clearly. After in-
jection of heparin (100 U/kg), under Intra Cardiac Ultra-
Sound (ICUS Sequoia Inc.) inserted into the right femoral
vein (figure 2) and fluoroscopic control, we inserted the
30 F sheath into the epigastric area through the cardiac
apex and up into the left ventricle, simulating the approach
for an off-pump aortic valve replacement. The thickness
of the ventricular wall at the insertion site was measured.
The sheath was then removed and the ventricle closed
with the occluder. Animals were followed up for three
hours, haemodynamic data (heart rate, ECG, blood pres-
sure, pO2, pCO2) was collected every 15 minutes. Pericar-
dial bleeding was assessed using the Smart Suction (Car-
dio Smart LLC, Fribourg. Switzerland) [7] and the blood
lost during the procedure was transfused back to the ani-
mal. Animals were then sacrificed and an examination of
the gross anatomy of the heart was carried out.
All the pigs received care in compliance with the
“Principles of Laboratory Animals” formulated by the Na-
tional Society of Medical Research and “the Guide for the
Care and Use of Laboratory Animals” prepared by the In-
stitute of Laboratory Animal Resources and published by
the National Institute of Health (NIH publication 85–23,
revised 1985). The protocol was approved by the Institu-
tional Committee on Animal Research. 
Data were analyzed with SPSS software (Statistical
Package for the Social Sciences). Paired t tests were used.
Values were reported as mean ± SD.
Figure 1
Front view of 12 mm Amplatz occluder. It is made of a nickel
– titanium alloy with a pre determined thermal memory
shape, which allows the device to be crimped into the deliv-
ery sheath. The device is mounted into a 30 F sheath to sim-
ulate the deployment of a 25 mm stented valve and its inser-
tion is aided by a semi rigid wire.
Figure 2
ICUS image. The probe is in the inferior vena cava – right
atrium. Left ventricle free wall (bottom) and mitral valve
(top) are identified to select the appropriate point to insert
the catheter for the trans-apical aortic valve replacement.
Results
The device was successfully used in four ani-
mals in less than a minute. Mean ventricular wall
thickness at the insertion site was 9 ± 2 mm. Acti-
vating Clotting Time was above 200 seconds in all
cases during the procedure. No major arrhythmias
were detected. All animals survived the procedure
with a mean arterial pressure of 50 ± 15 mm Hg.
Bleeding during deployment was 80 ± 20 ml and
over 3 hour period was 800 ± 20 ml. Gross anatomy
examination demonstrated the correct positioning
of the device. Detailed results are reported in 
table 1.
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Discussion
The transventricular approach for off-pump
aortic valve replacement with stented valves is con-
sidered to be the next revolution in cardiac surgery
and its impact on aortic valve disease treatment will
be as important if not more so, than that of angio-
plasty in coronary diseases. 
One of the key steps in the transventricular ap-
proach is the closure of the ventricular defect.
Every experimental cardiac surgeon knows that
safe closure of a 30 F hole in the free wall of the
left ventricle is a challenging procedure if extracor-
poreal circulation is not used. Moreover, since the
procedure is performed percutaneously closure of
the left ventricle defect seems almost impossible. 
The aim of this study was to assess if it is pos-
sible to do the seemingly impossible simply by ap-
plying advanced material technology. 
The concept of using a two square head niti-
nol device to close cardiac wall defects has been ex-
tensively investigated [8] and nowadays the en-
dovascular closure of a patent foramen ovale is
considered a routine procedure. The 12 mm Am-
plaz occluder has the same geometry as that used
for interatrial septal defect closure but the distance
between the two heads is increased to 7 mm on ac-
count of the thickness of the ventricle wall. Figure
3 shows the occluder on the left ventricle surface.
Despite several limitations, this study has
demonstrated that the Nitinol device described
could be the solution that permits a transventricu-
lar approach to off-pump aortic valve replacement.
The occluder is easy to use and the procedure is
feasible and reproducible. 
However, 800 cc bleeding over three hours
makes this device unsuitable for clinical use.
Therefore, the occluder requires technical im-
provement in order to dramatically reduce the
bleeding. It seems that bleeding occurs within the
Nitinol wires before thrombus formation. We are
now studying the addition of a pericardial cuff on
the endocardial head to prevent the bleeding. An-
other further concern is ventricle thickness. The
present configuration can not be deployed in cases
of left ventricle hypertrophy as the epicardial head
would not pass through the ventricle wall. The
third problem to solve before clinical application
of the occluder is to define a back up strategy in
case the device is lost during insertion as some-
times happens during the endovascular closure of
a patent foramen ovale. 
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Baseline During deployment After deployment
Mean Arterial Pressure 56 ± 5 mm Hg 48 ± 5mm Hg 55 ± 5 mm Hg
ECG Sinus rhythm Ventricular extrasystole Sinus rhythm
Bleeding – 80 ± 20 ml 800 ± 20 ml/3 h
P <0.001
Table 1
Cumulative results.
Figure 3
Intraoperative view
of pig’s heart. The 
30 F defect of the free
wall of the left ventri-
cle has been repaired
using a Nitinol oc-
cluder. After sacrifice
of the animal, the
delivery guide wire 
is re screwed in the
occluder and slightly
pulled back for
demonstration
purposes.
